Quantcast

Latest Sequenom Stories

2014-04-16 12:31:22

DUBLIN, Ireland, April 16, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/db83hw/molecular) has announced the addition of the "Molecular Diagnostics Markets" [http://www.researchandmarkets.com/research/db83hw/molecular ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The technologies that constitute molecular diagnostics - like first-generation amplification, DNA probes, fluorescent...

2014-04-09 16:25:20

DUBLIN, April 9, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/k3xnm6/molecular) has announced the addition of the "Molecular Diagnostics in Cancer Testing" [http://www.researchandmarkets.com/research/k3xnm6/molecular ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and...

2014-03-26 16:25:15

DUBLIN, March 26, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/3gb8bq/prenatal_and) has announced the addition of the "Prenatal and New-born Genetic Testing Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019" [http://www.researchandmarkets.com/research/3gb8bq/prenatal_and ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Genetic testing is a...

2014-03-24 08:27:17

ALBANY, New York, March 24, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Prenatal and Newborn Genetic Testing Market (PCR, FISH, aCGH, NIPT and MSS): Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" the global prenatal and newborn genetic testing market was valued USD 1.12 billion in 2012 and expected to grow at a CAGR of 26.9% from 2013 to 2019, to reach an estimated value of USD 8.37 billion...

2014-03-21 16:23:33

SAN DIEGO, March 21, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced a resolution of litigation between the Company and Paul Hawran. Mr. Hawran served as the Company's Chief Financial Officer from April 2007 until September 2009. Mr. Hawran resigned in September 2009. After September 2009, the Securities and Exchange Commission conducted an investigation concerning...

2014-03-19 04:21:22

DUBLIN, March 19, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/tdmwb8/noninvasive) has announced the addition of the "Non-Invasive Prenatal Testing (NIPT) Market Report" [http://www.researchandmarkets.com/research/tdmwb8/noninvasive ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Non-invasive prenatal testing is increasingly being adopted by high risk pregnant women for the...

2014-03-05 20:21:18

Harry Hixson to Retire as Sequenom CEO SAN DIEGO, March 5, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced that Harry F. Hixson, Jr., Ph.D., will retire as Chief Executive Officer (CEO), effective as of the Company's 2014 Annual Meeting on June 10, 2014. William J. Welch, the Company's current President and Chief Operating Officer, will assume the role of...

2014-03-03 08:30:45

SAN DIEGO, March 3, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the 26(th) Annual Roth Conference at the Ritz Carlton in Dana Point, CA on March 9-12, 2014. William Welch, President and Chief Operating Officer, and Carolyn D. Beaver, Vice President and Chief Accounting Officer, will present on Tuesday, March 11, beginning at...

2014-02-27 16:28:32

Record Quarterly and Annual Revenues; Annual Growth of 81% Over Prior Year SAN DIEGO, Feb. 27, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, today reported total revenues of $45.1 million for the fourth quarter and $162.4 million for the full year of 2013. Net loss was $18.9 million, or $0.16 per share, for the fourth quarter and $107.4 million, or $0.93 per share, for the full year. Recent Key...

2014-02-14 08:26:21

DUBLIN, Feb. 14, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/kkxpsb/molecular ) has announced the addition of the "Concise Analysis of the International Molecular Diagnostics Markets" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) The technologies that constitute molecular diagnostics - like first-generation amplification, DNA probes, fluorescent in situ hybridization (FISH), second-generation biochips and...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related